We connect you with specific subject matter experts to ensure support and recommendations tailored to your project.

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com
We will respond to you within 24 hours of your enquiry being received.
‍
You can also find Concept Life Sciences on the following platforms:
Poster

Poster

Context-of-Use Evaluation of a Simplified LC-MS/MS Assay for Endogenous NAD in Rodent Tissue

Close-up of a colorful fanned-out magazine or book pages showing curved layers.

Nicotinamide adenine dinucleotide (NAD) is a widely used endogenous biomarker of metabolic and mitochondrial health, but it is enzymatically and thermally labile—rapid ex vivo degradation is a major risk to accurate tissue quantitation. Published LC-MS/MS methods for tissue NAD are often complex, combining multiple enzymatic and chemical control steps that are difficult to translate into routine, high-throughput practice. Early discovery DMTA cycles run in parallel and need NAD data quickly to inform decisions, so the method had to be fast, simple, and low-cost per sample. We therefore simplified this down to two core principles—continuous temperature control and enzymatic inhibition — and built a practical cryolysis-based workflow around them. We evaluated the method through a Context-of-Use (CoU) lens appropriate to its intended application: discovery-level comparison of treated and control tissue, where our internal discovery guidance applies a 30% acceptance criterion rather than full regulatory validation.

Alternatively, search our entire resource library here